Abstract:To the Editor: We appreciate the comments by Levesque and colleagues and that they have brought attention to the consistencies between our data using the genetic Acvr1R206H/+ mouse model of heterotopic ossification (HO) and their model of HO formation in wild-type mice with spinal cord injury (SCI)-induced neurogenic heterotopic ossification (Genet and colleagues1 and Torossian and colleagues2). We agree that together these studies provide strong support for cytokine production by macrophages as a common inducer of HO. We previously have discussed common immunological contributions among multiple HO disorders,3 and the investigations of neurogenic heterotopic ossification (NHO)1, 2 importantly emphasize the role of macrophages and identify the cytokine Oncostatin M in a SCI and injury model that faithfully replicates symptoms of NHO. Our study investigating the role of inflammation in the initiation and development of HO in the rare genetic disorder fibrodysplasia ossifications progressiva (FOP)4 further emphasizes the integral role of inflammation and immune cells in HO pathology. In both our FOP Acvr1R206H/+ model and the NHO/SCI model, cardiotoxin injury to skeletal muscle was used to induce HO. We identified a robust cellular and molecular inflammatory response to injury in our Acvr1R206H model of HO4 with increased presence of innate immune cells, including macrophages and mast cells, as well as increased expression of proinflammatory cytokines, in mutant mice compared to controls. Upon depleting macrophages using clodronate-liposomes—also the same approach used by Genet and colleagues1—we likewise observed a significant decrease in HO formation.4 The relevancy of macrophages and cytokines in the development of HO across multiple disorders is becoming increasingly apparent. In addition to our study and the aforementioned NHO studies, macrophages have been implicated in the development of cardiac HO5 and in a BMP4 overexpression HO model that showed robustly reduced HO formation in response to clodronate-liposome-mediated depletion of macrophages.6 Furthermore, IL-6, a cytokine that we determined to be highly upregulated in Acvr1R206H/+ mutant tissue postinjury and in mast cells,4 has been previously reported as a predictive biomarker for HO development in blast injury patients,7, 8 as noted in our Discussion.4 We also want to highlight the contribution of mast cells to HO development in both FOP and nongenetic HO disorders. Genet and colleagues1 identified Substance P as a secreted factor that was significantly upregulated in human NHO patients, and treatment of their NHO/SCI model with an antagonist of Nk1r (the obligate Substance P receptor) significantly reduced HO volume. Notably, high levels of Substance P have been observed in early lesion biopsies from FOP patients,9 and inhibition of the Substance P neuroinflammatory pathway impaired HO in BMP4 overexpression and BMP2 implant models.9, 10 Our in vivo results showed that genetic ablation of mast cells in Acvr1R206H/+ mutant mice reduced HO volume similarly to macrophage depletion, and that combined depletion of both cell populations resulted in further reduction of HO formation.4 Our group further reported that inhibition of mast cell degranulation by cromolyn reduced HO formation.11 These data support that mast cells are additionally integral to the development of HO. The overlapping inflammatory features among genetic and nongenetic HO disorders has increasingly been confirmed over recent years, and future studies will further clarify commonalities, such as the role of additional cytokines, macrophage polarization, and other immune cell contributions to HO formation. Although it is important to note the unique aspects of FOP pathology, including accelerated cartilage and bone cell differentiation caused by the R206H mutation,12, 13 we fully agree with Levesque and colleagues that the overlapping inflammatory features among genetic and nongenetic HO disorders establishes the immune system as an attractive target for therapeutic intervention for all affected patients. All the authors state that they have no conflicts of interests.

Macrophage TGF-β signaling is critical for wound healing with heterotopic ossification after trauma

Regulation of heterotopic ossification by monocytes in a mouse model of aberrant wound healing

Macrophage-Derived TGF-β and VEGF Promote the Progression of Trauma-Induced Heterotopic Ossification

Regulation of heterotopic ossification through local inflammatory monocytes in a mouse model of aberrant wound healing

Macrophage migration inhibitory factor promotes heterotopic ossification by mediating ROS/HIF-1α positive feedback loop and activating Wnt/β-catenin signaling pathway

Macrophages in heterotopic ossification: from mechanisms to therapy

Macrophage-derived neurotrophin-3 promotes heterotopic ossification in rats

Inhibition of overactive TGF-β attenuates progression of heterotopic ossification in mice

Osteogenic Gene Expression Correlates With Development of Heterotopic Ossification in War Wounds

Hedgehog Signalling Contributes to Trauma-Induced Tendon Heterotopic Ossification and Regulates Osteogenesis Through Antioxidant Pathway in Tendon-Derived Stem Cells

Mesenchymal VEGFA induces aberrant differentiation in heterotopic ossification

Neuron-to-vessel signaling is a required feature of aberrant stem cell commitment after soft tissue trauma

Reply to Levesque et al. "Macrophages driving heterotopic ossification: Convergence of genetically-driven and trauma-driven mechanisms".

Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway

Reply To: Macrophages Driving Heterotopic Ossification: Convergence of Genetically‐Driven and Trauma‐Driven Mechanisms

Inhibition of NF-κB Signaling-Mediated Crosstalk Between Macrophages and Preosteoblasts by Metformin Alleviates Trauma-Induced Heterotopic Ossification

TGF-β1 Derived from Macrophages Contributes to Load-Induced Tendon-Bone Healing in the Murine Rotator Cuff Repair Model by Promoting Chondrogenesis

NF-κB/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification

Role Of Tgf Beta-Mediated Inflammation In Cutaneous Wound Healing

Tuning Macrophage Phenotype to Mitigate Skeletal Muscle Fibrosis

Mechanosensitive Control of Articular Cartilage and Subchondral Bone Homeostasis in Mice Requires Osteocytic Transforming Growth Factor β Signaling